Equity Profile

IRTC

iRhythm Holdings, Inc.

Health CareHealth Care Equipment$3.6B

Apr30Thu

Post-Earnings Recap

ReportedQ1-2026After Close4:05 PM EDT

iRhythm Holdings Beats on EPS, Stock Up 6.96%

Metric	Actual	Expected	Surprise
EPS	$-0.35	$-0.64	+37.83%
Revenue	N/A	$194M	N/A

management commentary, guidance changes, and full analysis available with Pro.

iRhythm Holdings Beats on EPS, Stock Up 6.96%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$-0.35	$-0.64	+37.83%
Revenue	N/A	$194M	N/A

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

What It Means

iRhythm Holdings reported a narrower-than-expected loss per share, which surprised analysts positively. This strong EPS performance contributed to a 6.96% increase in the stock price. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in digital health solutions for cardiac monitoring....

Key Metrics to Watch

EPS

Earnings per share is a critical indicator of profitability, and investors will be keen to see if the company can narrow its losses this quarter.

$-0.64

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

$194M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in digital health solutions for cardiac monitoring. With a focus on innovative technology, the company aims to improve patient outcomes and streamline the diagnosis of heart conditions, making it a significant player in the health care equipment sector.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+209.31%

Avg Stock Reaction

+0.87%

Last Quarter Recap

In the last quarter, iRhythm surprised analysts with a positive earnings per share of $0.29, significantly exceeding expectations. This performance marked a strong turnaround from previous quarters and contributed to a slight increase in stock price.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about iRhythm's upcoming earnings, with expectations for continued improvement in both revenue and earnings per share. However, the company has a history of mixed results, leading to uncertainty.

Bull Case

If iRhythm can report better-than-expected revenue and a narrower loss per share, it could signal a strong recovery and boost investor confidence.

Bear Case

Conversely, if the company fails to meet revenue expectations or reports larger losses, it may lead to a decline in stock price and investor sentiment.

Key Metrics to Watch

EPS

$-0.64

Earnings per share is a critical indicator of profitability, and investors will be keen to see if the company can narrow its losses this quarter.

Revenue

$194M

Revenue figures will provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the company achieve revenue of at least $194 million?

This figure is crucial for assessing market demand and the effectiveness of iRhythm's sales strategies.

Can iRhythm narrow its EPS loss to $-0.64 or better?

A smaller loss would indicate improved operational efficiency and could positively influence investor sentiment.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for iRhythm to improve its EPS significantly this quarter, given its recent positive surprise.

Supporting Evidence

The company has a history of beating EPS estimates, with a 63% success rate over the last eight quarters.

Options pricing indicates a higher expected move than historical averages, suggesting that traders anticipate significant volatility.

Recent performance improvements could indicate a trend that the market has not fully priced in.

Key Risk

If the company reports an EPS loss narrower than $-0.64, it could challenge the current negative sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal for iRhythm as it seeks to demonstrate a turnaround in profitability and revenue growth.

Bull Confirmed If

Achieving revenue of $194 million or more with an EPS loss of $-0.64 or better would confirm the bullish outlook.

Bear Confirmed If

Reporting revenue below $193 million or an EPS loss greater than $-0.64 would support the bearish case.

Pre-Earnings Positioning

Options Market

Implied Move

±10.59%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings report.

Options are pricing ±9.4% while IRTC has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

36.2%

Calls (0)P/C Ratio: 0.17Puts (200)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 9 of 23 (39%)

This setup has occurred 30 times across Health Care in the last 2 years. 14 of 23 (61%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 6.3%, with a raw directional average of +2.4% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If iRhythm beats expectations, history suggests the stock could see an average one-day move of +0.01%, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss could lead to a decline, with history suggesting an average one-day move of -0.26%, potentially causing investor concern.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or partnerships that could drive future revenue.
2Details on customer acquisition strategies and market expansion efforts.
3Insights into operational efficiencies that may lead to reduced costs.
4Management's outlook on the competitive landscape and how it plans to differentiate itself.
5Any commentary on regulatory changes that could impact the business.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Apr27

CINFReported

Cincinnati Financial Corporation

RecapView

Apr27

CCKReported

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in digital health solutions for cardiac monitoring....

Key Metrics to Watch

EPS

Earnings per share is a critical indicator of profitability, and investors will be keen to see if the company can narrow its losses this quarter.

$-0.64

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

$194M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+209.31%

Avg Stock Reaction

+0.87%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If iRhythm can report better-than-expected revenue and a narrower loss per share, it could signal a strong recovery and boost investor confidence.

Bear Case

Conversely, if the company fails to meet revenue expectations or reports larger losses, it may lead to a decline in stock price and investor sentiment.

Key Metrics to Watch

EPS

$-0.64

Earnings per share is a critical indicator of profitability, and investors will be keen to see if the company can narrow its losses this quarter.

Revenue

$194M

Revenue figures will provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the company achieve revenue of at least $194 million?

This figure is crucial for assessing market demand and the effectiveness of iRhythm's sales strategies.

Can iRhythm narrow its EPS loss to $-0.64 or better?

A smaller loss would indicate improved operational efficiency and could positively influence investor sentiment.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for iRhythm to improve its EPS significantly this quarter, given its recent positive surprise.

Supporting Evidence

The company has a history of beating EPS estimates, with a 63% success rate over the last eight quarters.

Options pricing indicates a higher expected move than historical averages, suggesting that traders anticipate significant volatility.

Recent performance improvements could indicate a trend that the market has not fully priced in.

Key Risk

If the company reports an EPS loss narrower than $-0.64, it could challenge the current negative sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal for iRhythm as it seeks to demonstrate a turnaround in profitability and revenue growth.

Bull Confirmed If

Achieving revenue of $194 million or more with an EPS loss of $-0.64 or better would confirm the bullish outlook.

Bear Confirmed If

Reporting revenue below $193 million or an EPS loss greater than $-0.64 would support the bearish case.

Pre-Earnings Positioning

Options Market

Implied Move

±10.59%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings report.

Options are pricing ±9.4% while IRTC has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

36.2%

Calls (0)P/C Ratio: 0.17Puts (200)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 9 of 23 (39%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If iRhythm beats expectations, history suggests the stock could see an average one-day move of +0.01%, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss could lead to a decline, with history suggesting an average one-day move of -0.26%, potentially causing investor concern.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or partnerships that could drive future revenue.
2Details on customer acquisition strategies and market expansion efforts.
3Insights into operational efficiencies that may lead to reduced costs.
4Management's outlook on the competitive landscape and how it plans to differentiate itself.
5Any commentary on regulatory changes that could impact the business.